ID

22184

Description

A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD) Medicine: rosiglitazone, Condition: Alzheimer's Disease, Phase: 2, Clinical Study ID: 49653/461, Sponsor: GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1

Link

https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1

Keywords

Versions (1)
  1. 5/22/17 5/22/17 -
Uploaded on

May 22, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Prior Medication Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

English

Prior Medication Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

1 forms  
Prior Medication
Description

Prior Medication

Alias
UMLS CUI-1
C0013227
Has the patient taken any medication within 1 week PRIOR to the first dose of study medication?
Description

Pharmaceutical preparations

Data type

boolean

Alias
UMLS CUI [1]
C0013227
If ´YES`, please record the medications below.
Description

specification

Data type

text

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C2348235
Prior Medication
Description

Prior Medication

Alias
UMLS CUI-1
C2826257
Drug name (Trade Name preferred)
Description

Drug name

Data type

text

Alias
UMLS CUI [1]
C0013227
Single Dose/ Unit (e.g. 500mg)
Description

Single dose/Unit

Data type

float

Measurement units
  • mg
Alias
UMLS CUI [1,1]
C2826257
UMLS CUI [1,2]
C1960417
mg
Frequency of this Dose (e.g. BID PRN)
Description

Frequency

Data type

text

Alias
UMLS CUI [1]
C3476109
Route
Description

Route

Data type

text

Alias
UMLS CUI [1]
C0013153
Indication
Description

Indication

Data type

text

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0013227
End Date
Description

End Date

Data type

date

Measurement units
  • Day Month Year
Alias
UMLS CUI [1]
C1531784
Day Month Year
Continuing at end of
Description

Continuing

Data type

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C1553904
Back to the top of the page

Similar models

Prior Medication Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Prior Medication
C0013227 (UMLS CUI-1)
Pharmaceutical preparations
Item
Has the patient taken any medication within 1 week PRIOR to the first dose of study medication?
boolean
C0013227 (UMLS CUI [1])
specification
Item
If ´YES`, please record the medications below.
text
C0013227 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
Item Group
Prior Medication
C2826257 (UMLS CUI-1)
Drug name
Item
Drug name (Trade Name preferred)
text
C0013227 (UMLS CUI [1])
Single dose/Unit
Item
Single Dose/ Unit (e.g. 500mg)
float
C2826257 (UMLS CUI [1,1])
C1960417 (UMLS CUI [1,2])
Frequency
Item
Frequency of this Dose (e.g. BID PRN)
text
C3476109 (UMLS CUI [1])
Route
Item
Route
text
C0013153 (UMLS CUI [1])
Indication
Item
Indication
text
C3146298 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
End Date
Item
End Date
date
C1531784 (UMLS CUI [1])
Continuing
Item
Continuing at end of
boolean
C0087111 (UMLS CUI [1,1])
C1553904 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial